BILLERICA, Mass.--(BUSINESS WIRE)--Entegris, Inc. (NASDAQ: ENTG), a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, announced today that it acquired Flex Concepts, Inc., a technology company focused on bioprocessing single-use bags, and fluid transfer solutions for the life sciences industry. Flex Concepts’ quick-turn, custom-configured, single-use product technology is a complement to Entegris existing single-use bag product line. With this combination, Entegris is now able to provide customers with a comprehensive solution set to meet emerging bioprocessing requirements.
Regulatory-driven process and production changes to pharmaceutical products are bringing incredible advancements to this industry. However, these advancements often require organizations to have highly-customized process solutions that can be delivered with speed to meet tight development timelines. With the technology from Flex Concepts, Entegris is able to better equip its customers to deliver the next healthcare treatment or disease prevention tool with the speed and flexibility they need to succeed in the market.
“In the pharma development pipeline, the quicker a potential process is developed, the faster life-saving treatments can be made available to patients,” says Eric Isberg director of Life Sciences, Entegris. “The addition of Flex Concepts capabilities will allow us to enrich our solutions set for fast growing single use bioprocessing applications.”
Neither the purchase price nor Flex Concepts financial results are material to Entegris overall financial statements.
Entegris is a leader in specialty chemicals and advanced materials solutions for the microelectronics industry and other high-tech industries. Entegris is ISO 9001 certified and has manufacturing, customer service and/or research facilities in the United States, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea and Taiwan.
Additional information can be found at www.entegris.com.
FORWARD LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include statements related to the acquisition; future financial and operating results; future opportunities for the combined company; market and technology trends; and other matters. These statements involve risks and uncertainties that may cause actual results to differ including, but not limited to, the ability to successfully integrate the acquisition; risks that the transaction disrupts current plans and operations; the weakening of global and/or regional economic conditions which could decrease the demand for our products and solutions; our ability to continue technological innovation and introduce new products to meet our customers' rapidly changing requirements; and other risk factors and additional information described in our filings with the Securities and Exchange Commission, including under the heading “Risks Factors" in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed on February 15, 2018, and in our other periodic filings. Entegris assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.